6 research outputs found
Binimetinib, encorafenib and cetuximab (BEACON Trial) combination therapy for patients with BRAF V600E-mutant metastatic colorectal cancer
Enabling actuation and sensing in organs-on-chip using electroactive polymers
•Actuation has been succesfully performed for 2h30 with no side effects nordelimination of the human tissue •0.1 % strain has been achieved during the actutaion mode, close to thestrain experienced in vivo by vSMCs •0.72 V/mm sensitivity has been shown on the sensing mode •Batch fabrication and downscaling will be targetted in the near future •Actual sensing of the cells’ contraction will be reserved for further workgreenElectronic Components, Technology and MaterialsMechatronic Systems Desig